Original Paper
Cell Death and Differentiation (2008) 15, 494–503; doi:10.1038/sj.cdd.4402282; published online 7 December 2007
Regulating Vav1 phosphorylation by the SHP-1 tyrosine phosphatase is a fine-tuning mechanism for the negative regulation of DISC formation and Fas-mediated cell death signaling
Edited by JA Cidlowski
G Koncz1,2, K Kerekes1,2, K Chakrabandhu1 and A-O Hueber1
1Equipe Labelisée La Ligue, Institute of Signalling, Developmental Biology and Cancer Research, CNRS UMR 6543, Nice, France
Correspondence: A-O Hueber, Institute of Signalling, Developmental Biology and Cancer Research, CNRS UMR 6543, Centre A Lacassagne, 33, Avenue de Valombrose, Nice 06189, France. Tel: +33 49203 1241; Fax: +33 49203 1245; E-mail: hueber@unice.fr
2Current address: Immunology Research Group of the Hungarian Academy of Sciences, University Eötvös Lorand, Pazmany s 1/C, Budapest, Hungary.
Received 7 March 2007; Revised 17 October 2007; Accepted 24 October 2007; Published online 7 December 2007.
Abstract
The actin cytoskeleton association is required for caspase 8-independent Fas/CD95 receptor internalization, a critical step for an optimal death-inducing signaling complex formation along the endocytic pathway, leading to efficient activation of the caspase cascade and, ultimately, cell death. However, the way in which this initiation phase of Fas receptor signaling is regulated is still unknown. We report herein that, in B cells, upon Fas engagement, the tyrosine phosphatase SHP-1-regulated Vav dephosphorylation, by downmodulating the Fas–ezrin–actin linkage is a fine-tune switch-off mechanism that the cell uses as a way to terminate the receptor internalization, controlling therefore the time and extent of the DISC formation and cell death.
Keywords:
Fas, signaling, Vav, SHP-1
Abbreviations:
DED, death effector domain; DISC, death-inducing signaling complex; DR, death receptor; FasL, Fas ligand; LtnA, latrunculin A; SDS-PAGE, sodium dodecyl sulfate-polyacrylamide gel electrophoresis; SHP-1, SH2-containing PTP1 protein; TNFSFR, tumor necrosis factor superfamily receptor
MORE ARTICLES LIKE THIS
These links to content published by NPG are automatically generated
NEWS AND VIEWS
A SADS defect in tumor cells provides optimism
Nature Medicine News and Views (01 Jan 2001)
Nature Cell Biology News and Views (01 Oct 1999)
Fas ligand?cought between scylla and charybdis
Nature Medicine News and Views (01 Jan 1998)
Nature Medicine News and Views (01 Jun 2004)

